Sangamo Therapeutics, Inc. Alternatives & Competitors
12 companies similar to Sangamo Therapeutics, Inc. — We're committed to translating our ground-breaking science into genomic medicine...
Intellia Therapeutics, Inc.
Developing curative genome editing treatments
Cambridge, United States
Rocket Pharmaceuticals
Seeking gene therapy cures
Cranbury, United States
Arbor Biotechnologies
Genetic medicines for genetic diseases
Cambridge, United States
REGENXBIO
Seeking to improve lives through the curative potential of gene therapy.
Rockville, United States
Track all Sangamo Therapeutics, Inc. competitors
Get real-time alerts when any of these companies raise funding, hire, or show growth signals.
Evox Therapeutics Ltd
Changing the course of CNS disease
Oxford, United Kingdom
Dianthus Therapeutics, Inc.
Building a leading biotech company focused in severe autoimmune diseases.
United States
Arrakis Therapeutics
Arrakis is on a path to bring powerful new RNA-targeted small molecule (rSM) therapies to...
Waltham, United States
SonoThera
SonoThera is developing ultrasound-mediated nonviral genetic therapies.
South San Francisco, Unit...
Agomab
Ghent, Belgium
Octant
Developing synthetic technology and applying next-generation DNA sequencing, gene synthesi...
Emeryville, United States
Affinia Therapeutics
Building the next generation of gene therapies
Waltham, United States
ReCode Therapeutics
Powering the next wave of genetic medicines through superior delivery
United States
About Sangamo Therapeutics, Inc.
We're committed to translating our ground-breaking science into genomic medicines that transform patients’ lives.
Genetic research and development, Therapeutic solution creation, Clinical trial execution, Scientific collaboration and partnerships
Patients with severe genetic diseases, Healthcare professionals, Pharmaceutical partners, Biotech research organizations
Genomic Medicines, Gene Therapy, Genome Editing, Clinical Trials, In Vivo Human Genome Editing, MPS II, MPS I, Hemophilia A, Hemophilia B, Beta Thalassemia, Fabry Disease, Cell Therapy, Tauopathies, Immunology, Neuropathic Pain, Prion Disease
B2B, B2D
Licensing, Performance Based, Project Based
Frequently Asked Questions
Don't just read about them. Follow them.
BounceWatch watches Sangamo Therapeutics, Inc. and millions of other companies. When one raises money, hires quickly or changes its product, we tell you the same day.
Compiled from the BounceWatch company index. We last looked at Sangamo Therapeutics, Inc. on 9 Jun 2026. The 12 companies listed here were last checked between 11 Mar 2026 and 16 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
